Stockreport

Annovis Bio Publishes Results of Alzheimer’s and Parkinson’s Animal Studies

Annovis Bio, Inc.  (ANVS) 
PDF BERWYN, Pa., April 23, 2020 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease, Parkinso [Read more]